Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
Aureka Biotechnologies announced its AuraIDE foundation model won first place in the AIntibody global AI antibody design competition, with results published in Nature Biotechnology. The winning AI-designed antibody achieved an affinity of 94.7pM, surpassing the best experimental result of 113 pM and representing a 2,000-fold improvement over the parental antibody.
Key figures
- Participants
- 29
- Funding raised
- $200 million
- Improvement fold
- 2,000-fold
- Winning affinity
- 94.7pM
- Best experimental affinity
- 113 pM
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.